Dr. Jennifer Taylor-Cousar, a tenured professor of adult and pediatric pulmonary medicine and co-director of the Adult CF Program at National Jewish Health, gives a comprehensive overview of nucleic acid-based therapies (NABT), which aim to deliver the correct instructions to the cell for making a functional CFTR protein. She reviews lessons learned from historical NABT efforts, pre-clinical data supporting renewed clinical investigative efforts, and ongoing clinical trial designs and updates. This presentation was part of CFRI's 37th National CF Education Conference.
CFRI's 37th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Viatris, Gilead Sciences, AbbVie, and the Boomer Esiason Foundation.

Ver todos los episodios